L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm.
Clinical Haematology Department, Amiens University Hospital, Amiens, France.
Bérengère
B
Gruson
Ioana
I
Vaida
Lavinia
L
Merlusca
Amandine
A
Charbonnier
Anne
A
Parcelier
Gandhi
G
Damaj
Bruno
B
Royer
Jean-Pierre
JP
Marolleau
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects; D019046:Bone Marrow Neoplasms / Q000188:drug therapy*; D003713:Dendritic Cells / Q000473:pathology*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
D003907:Dexamethasone; D001215:Asparaginase; D008727:Methotrexate
L-asparaginase; blastic plasmacytoid dendritic cell neoplasm; methotrexate; plasmacytoid dendritic cell